✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Biontech SE

Common Name
Biontech
Country
Germany
Sector
Healthcare
Industry
Biotechnology
Employees
6,772
Ticker
BNTX
Exchange
Nasdaq
Description
BioNTech SE is a biotechnology company focused on the development of immunotherapies and mRNA-based medicines for cancer and infectious diseases. The company’s current portfolio includes oncology prog...

Biontech's GHG Emissions Data Preview

In 2025, Biontech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Biontech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022-2019
Total Scope 1
2,209a
2,415a
1,342a
Total Scope 2
Market-Based
5,794a
4,034a
3,339a
Location-Based
26,762a
16,205b
N/A
Total Scope 3
703,634a
886,448a
529,501a
Total Scope 1 Revenue Intensity (tCO2e/$M)
0.6547a
0.8436a
0.3175a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=BNTX&reporting_period=2025"

Verified Sources Behind Biontech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Biontech's Sustainability Report 2025
b. Biontech's Sustainability Report 2024
c. Biontech's Sustainability Report 2023

Insights into Biontech's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Biontech amounted to 28,971 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Biontech increased by 55.59%, suggesting that the company faced challenges in reducing its emissions from its core operations.ab

Biontech's Scope 1 Emissions Over Time

201920202021202220232024202506501.3 k1.95 k2.6 ktCO2e+16%+26%-2%+55%+80%-9%
  • Total Scope 1
  • Year-over-Year Change

What are Biontech's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Biontech were 2,209 metric tons of CO₂ equivalent (tCO₂e).a

Has Biontech reduced its Scope 1 emissions over time?

Since 2019, Biontech's Scope 1 emissions have increased by 263.92%, reflecting a rising long-term trend in Scope 1 emissions over time.ac

Compared to the previous year (2024), Biontech's Scope 1 emissions decreased by 8.53%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Biontech's Scope 2 emissions?

In 2025, Biontech reported Scope 2 greenhouse gas (GHG) emissions of 5,794 tCO₂e using the market-based method and 26,762 tCO₂e using the location-based method.a

Has Biontech reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Biontech's Scope 2 emissions (Location-Based) rose by 65.15% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energyab

What methodology does Biontech use for Scope 2 reporting?

In 2025, Biontech reported its Scope 2 emissions using the market-based method and using the location-based method.a

Biontech's Scope 2 Emissions Over Time

201920202021202220232024202507 k14 k21 k28 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Biontech's Value Chain Emissions

In 2025, Biontech reported 703,634 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Biontech includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Biontech's Scope 3 Emissions Over Time

20192020202120222023202420250400 k800 k1.2 M1.6 MtCO2e-34%+88979%-23%-53%+67%-21%
  • Total Scope 3
  • Year-over-Year Change

What are Biontech's Scope 3 emissions?

In 2025, Biontech reported total Scope 3 emissions of 703,634 metric tons of CO₂ equivalent (tCO₂e).a

Has Biontech reduced its Scope 3 emissions over time?

Since 2019, Biontech's Scope 3 emissions have increased by 28,678.49%, reflecting a rising long-term trend in Scope 3 emissions over time.ac

Compared to the previous year (2024), Biontech's Scope 3 emissions decreased by 20.62%, highlighting the company's efforts to lower indirect emissions from its value chain.a

Insights into Biontech’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Biontech reported Scope 1 greenhouse gas (GHG) emissions of 2,209 tCO₂e and total revenues of USD 3,374 millions. This translates into an emissions intensity of 0.65 tCO₂e per millions USD.a

Biontech's Scope 1 Emissions Intensity Compared to Peers

202002,00020,000200,000Scope 1 Emissions (tCO2e)505002,00010,00050,000Revenues (Millions of USD)argenxYear: 2025Scope 1: 2,120 tCO2eRevenue: $M 4,154Scope 1 Intensity: 0.51 tCO2e/$MRegeneron PharmaceuticalsYear: 2025Scope 1: 89,990 tCO2eRevenue: $M 14,343Scope 1 Intensity: 6.27 tCO2e/$MVertex PharmaceuticalsYear: 2025Scope 1: 12,296 tCO2eRevenue: $M 12,001Scope 1 Intensity: 1.02 tCO2e/$MIonis PharmaceuticalsYear: 2025Scope 1: 2,615 tCO2eRevenue: $M 944Scope 1 Intensity: 2.77 tCO2e/$MSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 217Scope 1 Intensity: 29.23 tCO2e/$MAkesoYear: 2025Scope 1: 6,623 tCO2eRevenue: $M 437Scope 1 Intensity: 15.17 tCO2e/$MAscendis PharmaYear: 2025Scope 1: 69 tCO2eRevenue: $M 847Scope 1 Intensity: 0.08 tCO2e/$MInsmedYear: 2025Scope 1: 2,622 tCO2eRevenue: $M 606Scope 1 Intensity: 4.32 tCO2e/$MIncyteYear: 2025Scope 1: 8,872 tCO2eRevenue: $M 5,141Scope 1 Intensity: 1.73 tCO2e/$MFortrea HoldingsYear: 2025Scope 1: 1,418 tCO2eRevenue: $M 2,723Scope 1 Intensity: 0.52 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MBioconYear: 2025Scope 1: 27,951 tCO2eRevenue: $M 1,762Scope 1 Intensity: 15.87 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,248Scope 1 Intensity: 10.66 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MAlnylam PharmaceuticalsYear: 2025Scope 1: 6,785 tCO2eRevenue: $M 3,714Scope 1 Intensity: 1.83 tCO2e/$MSamsung BiologicsYear: 2024Scope 1: 71,972 tCO2eRevenue: $M 3,099Scope 1 Intensity: 23.22 tCO2e/$MJazz PharmaceuticalsYear: 2025Scope 1: 4,758 tCO2eRevenue: $M 4,268Scope 1 Intensity: 1.11 tCO2e/$MSino BiopharmaceuticalYear: 2024Scope 1: 18,239 tCO2eRevenue: $M 3,955Scope 1 Intensity: 4.61 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,559Scope 1 Intensity: 14.99 tCO2e/$MInnovent BiologicsYear: 2025Scope 1: 7,803 tCO2eRevenue: $M 1,863Scope 1 Intensity: 4.19 tCO2e/$MGenmabYear: 2025Scope 1: 758 tCO2eRevenue: $M 586Scope 1 Intensity: 1.29 tCO2e/$MModernaYear: 2025Scope 1: 10,463 tCO2eRevenue: $M 1,922Scope 1 Intensity: 5.44 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MBiontechYear: 2025Scope 1: 2,209 tCO2eRevenue: $M 3,374Scope 1 Intensity: 0.65 tCO2e/$M

How does Biontech's GHG emissions intensity compare to its peers?

In 2025, Biontech reported a Scope 1 emissions intensity of 0.65 tCO₂e per millions USD. Compared to the peer group median of 4.47, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Biontech rank on GHG emissions intensity within its industry?

In 2025, Biontech ranked 4 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Biontech among the top performers, with one of the lowest emissions intensities relative to peers.a

Insights into Biontech's Total Carbon Footprint

In 2025, Biontech reported a total carbon footprint of 732,605 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 19.06% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.ab

The largest contributor to Biontech's total carbon footprint was Scope 3 emissions, accounting for 96.05% of the company's total carbon footprint, followed by Scope 2 emissions at 3.65%.a

Want Full Access to Biontech's GHG Emissions Dataset?
Start 30-Day Free Trial